FOR LABORATORY RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION
◀ COMPAREGIGARESEARCH
HEAD-TO-HEAD

BPC-157 VS TB-500

BPC-157 and TB-500 are the two most-discussed recovery research peptides · different mechanisms, often stacked. BPC-157 is a 15-amino-acid pentadecapeptide acting through VEGF angiogenesis, growth-hormone-receptor upregulation, and the cytoprotection paradigm. TB-500 is a 7-amino-acid Thymosin Beta-4 fragment that sequesters G-actin to promote cell migration. The two are complementary rather than competitive.

BPC-157 card
A · No. 003
BPC-157

Pentadecapeptide Cytoprotection

TB-500 card
B · No. 007
TB-500

Thymosin Beta-4 Fragment

SIDE BY SIDE

FIELD
A · BPC-157
B · TB-500
Class
Synthetic 15-aa peptide (gastric-origin fragment)
Synthetic 7-aa Thymosin Beta-4 fragment
Sequence
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Ac-LKKTETQ (residues 17–23 of parent Tβ4)
Mechanism
VEGF / NO / GHR upregulation · cytoprotection
G-actin sequestration · cell migration
Half-life
~4 hours (rat IP)
~2 hours (rat)
Primary research focus
GI mucosal protection · tendon-ligament healing
Cardiac repair · cell migration · anti-fibrotic
FDA status
FDA Cat 2 503A bulks list (Sept 2023) · research-use only
Not FDA-approved · research-use only
WADA status
Prohibited at all times (S0)
Prohibited at all times (S2)
Stability in gastric juice
Stable >24 hr (unusual)
Not orally stable

WHICH IS BETTER · BY GOAL

Tendon / ligament healingTIE

Animal-model evidence for both. Mechanisms are complementary; most community protocols stack them rather than choose.

GI mucosal protectionA · BPC-157

BPC-157 has the Sikiric multi-paper rat-model evidence base for gastric and intestinal cytoprotection. TB-500 not specifically studied here.

Cardiac repair (preclinical)B · TB-500

Bock-Marquette 2004 Nature paper on Thymosin Beta-4 in mouse MI is the landmark. BPC-157 has some cardiac-protective signal but TB-500 / Tβ4 owns this category.

Cell-migration biologyB · TB-500

Direct actin-cytoskeleton-driven cell migration is TB-500's mechanism. BPC-157 acts more permissively via VEGF and other signaling.

STACKING NOTE

BPC-157 + TB-500 is the most commonly referenced recovery research stack in community protocols (see the Classic Recovery stack). No published RCT validates the specific combination, but the mechanistic complementarity is the basis.

SOURCED FROM GIGACOMPOUNDS

Both compounds are available as research-grade material at GigaCompounds · ≥99% purity · per-batch CoA. For laboratory research use only.

SOURCE AT GIGACOMPOUNDS ▶
© 2026 GigaCompounds LLC · For Laboratory Research Use Only